WO2011141891A1
|
|
Use of cycloundecadepsipeptide compounds
|
TW201117822A
|
|
Cycloundecadepsipeptide compounds and use of said compounds as a medicament
|
CA2741829A1
|
|
Cycloundecadepsipeptide compounds and use of said compounds as a medicament
|
CN101677959A
|
|
Slow release pharmaceutical composition made of microparticles
|
EP1667790A1
|
|
Device and method for making particles
|
WO2005107715A1
|
|
Implantable composition
|
BRPI0407818A
|
|
subcutaneous distribution system, process for its preparation and use for the treatment of cholinergic deficiency diseases
|
CN1761452A
|
|
Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
|
AU2002328388B2
|
|
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
WO03031467A2
|
|
Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
|
WO02058672A2
|
|
Microparticles of biodegradable polymer encapsulating a biologically active substance
|
WO02058671A1
|
|
Burst free pharmaceutical microparticules
|
EP1044683A1
|
|
One-step dispersion method for the microencapsulation of water soluble substances
|
EP1053019A1
|
|
Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
|
EP1008355A1
|
|
Method for identifying or analyzing polymer linkage sites on macromolecules using amino acid report binding
|
US6319512B1
|
|
Implants for controlled release of pharmaceutically active principles and method for making same
|
FR2777895A1
|
|
Non crosslinked block polymer useful as support for active agents e.g. antigens and vaccines
|
US6258351B1
|
|
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
FR2748205A1
|
|
PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF INSOLUBLE ACTIVE SUBSTANCES
|
CH688269A5
|
|
Ultra Centrifugal Mill and its implementation for cryogenic grinding of thermally sensitive material.
|